DRRX
Price
$1.93
Change
+$0.01 (+0.52%)
Updated
Sep 8, 12:41 PM (EDT)
Capitalization
59.31M
PAHC
Price
$39.47
Change
+$0.02 (+0.05%)
Updated
Sep 8, 01:20 PM (EDT)
Capitalization
1.6B
58 days until earnings call
Interact to see
Advertisement

DRRX vs PAHC

Header iconDRRX vs PAHC Comparison
Open Charts DRRX vs PAHCBanner chart's image
DURECT
Price$1.93
Change+$0.01 (+0.52%)
Volume$100
Capitalization59.31M
Phibro Animal Health
Price$39.47
Change+$0.02 (+0.05%)
Volume$2.48K
Capitalization1.6B
DRRX vs PAHC Comparison Chart in %
Loading...
DRRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PAHC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DRRX vs. PAHC commentary
Sep 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DRRX is a Hold and PAHC is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 08, 2025
Stock price -- (DRRX: $1.91 vs. PAHC: $39.45)
Brand notoriety: DRRX and PAHC are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: DRRX: 46% vs. PAHC: 140%
Market capitalization -- DRRX: $59.31M vs. PAHC: $1.6B
DRRX [@Pharmaceuticals: Generic] is valued at $59.31M. PAHC’s [@Pharmaceuticals: Generic] market capitalization is $1.6B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $67.95B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.93B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DRRX’s FA Score shows that 0 FA rating(s) are green whilePAHC’s FA Score has 1 green FA rating(s).

  • DRRX’s FA Score: 0 green, 5 red.
  • PAHC’s FA Score: 1 green, 4 red.
According to our system of comparison, PAHC is a better buy in the long-term than DRRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DRRX’s TA Score shows that 3 TA indicator(s) are bullish while PAHC’s TA Score has 5 bullish TA indicator(s).

  • DRRX’s TA Score: 3 bullish, 5 bearish.
  • PAHC’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, PAHC is a better buy in the short-term than DRRX.

Price Growth

DRRX (@Pharmaceuticals: Generic) experienced а -0.52% price change this week, while PAHC (@Pharmaceuticals: Generic) price change was +6.77% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -0.06%. For the same industry, the average monthly price growth was +9.04%, and the average quarterly price growth was +87.12%.

Reported Earning Dates

PAHC is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (-0.06% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PAHC($1.6B) has a higher market cap than DRRX($59.3M). DRRX YTD gains are higher at: 154.667 vs. PAHC (90.357). DRRX has less debt than PAHC: DRRX (1.75M) vs PAHC (762M).
DRRXPAHCDRRX / PAHC
Capitalization59.3M1.6B4%
EBITDA-15.23MN/A-
Gain YTD154.66790.357171%
P/E RatioN/A33.15-
Revenue1.66MN/A-
Total Cash6.5MN/A-
Total Debt1.75M762M0%
FUNDAMENTALS RATINGS
DRRX vs PAHC: Fundamental Ratings
DRRX
PAHC
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
69
Overvalued
29
Undervalued
PROFIT vs RISK RATING
1..100
10037
SMR RATING
1..100
9964
PRICE GROWTH RATING
1..100
3536
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
5049

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PAHC's Valuation (29) in the Pharmaceuticals Major industry is somewhat better than the same rating for DRRX (69) in the Pharmaceuticals Other industry. This means that PAHC’s stock grew somewhat faster than DRRX’s over the last 12 months.

PAHC's Profit vs Risk Rating (37) in the Pharmaceuticals Major industry is somewhat better than the same rating for DRRX (100) in the Pharmaceuticals Other industry. This means that PAHC’s stock grew somewhat faster than DRRX’s over the last 12 months.

PAHC's SMR Rating (64) in the Pharmaceuticals Major industry is somewhat better than the same rating for DRRX (99) in the Pharmaceuticals Other industry. This means that PAHC’s stock grew somewhat faster than DRRX’s over the last 12 months.

DRRX's Price Growth Rating (35) in the Pharmaceuticals Other industry is in the same range as PAHC (36) in the Pharmaceuticals Major industry. This means that DRRX’s stock grew similarly to PAHC’s over the last 12 months.

DRRX's P/E Growth Rating (100) in the Pharmaceuticals Other industry is in the same range as PAHC (100) in the Pharmaceuticals Major industry. This means that DRRX’s stock grew similarly to PAHC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
DRRXPAHC
RSI
ODDS (%)
Bearish Trend 4 days ago
87%
Bearish Trend 4 days ago
71%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
61%
Momentum
ODDS (%)
Bullish Trend 4 days ago
77%
Bullish Trend 4 days ago
79%
MACD
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
72%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
89%
Bullish Trend 4 days ago
70%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
76%
Bullish Trend 4 days ago
73%
Advances
ODDS (%)
Bullish Trend 15 days ago
79%
Bullish Trend 4 days ago
72%
Declines
ODDS (%)
Bearish Trend 21 days ago
89%
Bearish Trend 7 days ago
71%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
69%
Aroon
ODDS (%)
N/A
Bullish Trend 4 days ago
74%
View a ticker or compare two or three
Interact to see
Advertisement
DRRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PAHC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
REOP46.001.50
+3.37%
Reo Plastics, Inc.
EHGRF0.08N/A
N/A
Star Entertainment Group Limited
ALEGF7.65N/A
N/A
ALLEGRO EU SA
NMKBP59.99N/A
N/A
Niagara Mohawk Power Corp.
PRMRF14.62-0.34
-2.27%
Paramount Resources Ltd.

DRRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, DRRX has been loosely correlated with BNXTF. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if DRRX jumps, then BNXTF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DRRX
1D Price
Change %
DRRX100%
N/A
BNXTF - DRRX
62%
Loosely correlated
+2.55%
HLBBF - DRRX
38%
Loosely correlated
N/A
ANIP - DRRX
38%
Loosely correlated
-0.68%
PAHC - DRRX
30%
Poorly correlated
+0.97%
SIGA - DRRX
21%
Poorly correlated
-0.82%
More

PAHC and

Correlation & Price change

A.I.dvisor indicates that over the last year, PAHC has been loosely correlated with AMRX. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if PAHC jumps, then AMRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PAHC
1D Price
Change %
PAHC100%
+0.97%
AMRX - PAHC
46%
Loosely correlated
+0.73%
ZTS - PAHC
41%
Loosely correlated
+0.08%
PBH - PAHC
38%
Loosely correlated
-2.55%
ELAN - PAHC
37%
Loosely correlated
+5.50%
VTRS - PAHC
36%
Loosely correlated
+1.65%
More